Asston Pharmaceuticals Limited (BOM:544445)
81.90
+1.95 (2.44%)
At close: Aug 17, 2026
Asston Pharmaceuticals Market Cap
Asston Pharmaceuticals has a market cap or net worth of 697.21 million as of August 17, 2026. Its market cap has decreased by -22.04% in one year.
Market Cap
697.21M
Enterprise Value
735.38M
Revenue
254.69M
Ranking
n/a
PE Ratio
16.65
Stock Price
81.90
ChartMarket Cap Chart
Since July 16, 2025, Asston Pharmaceuticals's market cap has decreased from 1.06B to 697.21M, a decrease of -34.45%. That is a compound annual growth rate of -32.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 697.21M | -0.76% |
| Dec 31, 2025 | 702.57M | -33.95% |
| Jul 16, 2025 | 1.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Denis Chem Lab | 975.53M |
| Concord Drugs | 927.52M |
| Makers Laboratories | 921.05M |
| Mercury Laboratories | 917.16M |
| Amwill Health Care | 835.15M |
| Onyx Biotec | 797.82M |
| Godavari Drugs | 782.80M |
| Source Natural Foods and Herbal Supplements | 731.88M |